OZK Earnings

OZK reported its earnings on 2026-01-20, showcasing a revenue of 705.00M against an estimate of 433.00M, resulting in a 62.89% surprise. The EPS was 1.53, surpassing the expected 1.56 by -1.92% . The stock experienced a 0.06% price change on the earnings day and a -3.2% change over the next five days, reflecting market reactions to the results.

Following OZK's earnings announcement on 2026-01-20, the stock price moved by 0.06% on the day of the release. Over the subsequent five days, it saw a -3.20% change. Historically, OZK's stock price tends to shift by an average of +0.62% in the 10 days leading up to earnings and +1.34% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate OZK’s annual revenue to reach 424.00M, while the EPS is projected at 1.00. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by -0% and EPS estimates Revise Downward by -0.01% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between OZK's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were No Change by -0%, while EPS estimates moved Revise Downward by -0.01% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, OZK's stock price typically moves by +0.62% in the 10 days before its earnings and +1.34% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 1.00 and revenue of 424.00M.

The earnings call lacked detailed financial performance data and strategic initiatives, indicating a neutral sentiment. The Q&A revealed management's optimism for future growth, particularly in fee income and loan growth, but also highlighted risks in the life sciences market and non-performing loans. The lack of guidance on key financial metrics and strategic plans, coupled with management's cautious optimism, suggests a neutral market reaction. With a market cap of approximately $4.5 billion, significant short-term stock price movements are unlikely.